Lung cancer is the leading cause of death from cancer in Western count
ries. For improved diagnosis and refined therapeutical approaches it i
s of major importance to understand by what mechanisms carcinoma of th
e lung develop. The analysis of primary lung cancer revealed specific
chromosomal alterations and allelic losses of the short arm of chromos
ome 3. Genetic aberrations have been observed in proto-oncogenes such
as H-ras, K-ras, C-myc and raf-1 as well as in the tumor suppressor ge
nes Rb and p53. Rearrangement of rlf and elevated expression in certai
n lung tumors have also been reported. The development of lung cancer
also involves the altered activation of genes coding for growth factor
s such as TGF beta 2 and certain growth factor receptor genes such as
c-erbB-2, HEK2 and FGFR-4.